These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species. Climo MW; Markowitz SM; Williams DS; Hale-Cooper CG; Archer GL J Antimicrob Chemother; 1997 Jul; 40(1):59-66. PubMed ID: 9249205 [TBL] [Abstract][Full Text] [Related]
30. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci. Mordenti JJ; Davis RH; Lammel CJ; Brooks GF Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453 [TBL] [Abstract][Full Text] [Related]
31. Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin. Norden CW; Shaffer M J Infect Dis; 1983 Feb; 147(2):352-7. PubMed ID: 6827150 [TBL] [Abstract][Full Text] [Related]
32. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology. Credito K; Lin G; Appelbaum PC Antimicrob Agents Chemother; 2007 Apr; 51(4):1504-7. PubMed ID: 17220402 [TBL] [Abstract][Full Text] [Related]
33. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin. Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267 [TBL] [Abstract][Full Text] [Related]
34. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. Rose WE; Poppens PT J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338 [TBL] [Abstract][Full Text] [Related]
36. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci. Lowy FD; Chang DS; Lash PR Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016 [TBL] [Abstract][Full Text] [Related]
37. Rifampin in the treatment of serious staphylococcal infections. Swanberg L; Tuazon CU Am J Med Sci; 1984; 287(3):49-54. PubMed ID: 6563847 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus. Baltch AL; Ritz WJ; Bopp LH; Michelsen PB; Smith RP Antimicrob Agents Chemother; 2007 Apr; 51(4):1559-62. PubMed ID: 17283190 [TBL] [Abstract][Full Text] [Related]
39. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Shelburne SA; Musher DM; Hulten K; Ceasar H; Lu MY; Bhaila I; Hamill RJ Antimicrob Agents Chemother; 2004 Oct; 48(10):4016-9. PubMed ID: 15388469 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. Bayer AS; Lam K J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]